// PERSON
Omri Amirav-Drory
ROLE PARTNER AT NFXMENTIONS 1LAST SEEN SEPTEMBER 8, 2026
// BIO
Omri Amirav-Drory is a General Partner at NFX, where he leads NFX Bio and invests in scientist-founders at the intersection of technology and biology. He previously founded Genome Compiler, a software company for genetic engineers that was acquired by Twist Bioscience, where he subsequently served as Head of Corporate Development. He holds a Ph.D. in Biochemistry from Tel Aviv University and completed a postdoctoral fellowship at Stanford University School of Medicine.
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
mention·Data Driven VC·SEPTEMBER 8, 2026
“Underpaid founders tend to quit before the real outcome arrives.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.